Lisa Suennen
Lisa Suennen has spent nearly 30 years as an entrepreneur, venture investor and advisor in the healthcare industry. She currently serves as Senior Managing Director at GE Ventures, leading the firm’s healthcare venture fund. Lisa is also co-founder of CSweetener, a not-for-profit company focused on matching women in and nearing the healthcare C-Suite with mentors who have been there and wish to give back. She is a member of the faculty at the UC Berkeley Haas School of
Business, where for 10 years she has taught classes on venture capital and the changing healthcare economy.
Prior to joining GE Ventures, Lisa operated Venture Valkyrie Consulting for 3 years, advising large corporations around corporate venture capital, new business creation and digital health strategy. Prior to that she spent 15 years as a Partner at Psilos Group, a successful healthcare-focused venture capital firm. Lisa is currently a Board Member of Evidation Health, Health Reveal, Gravie, the Dignity Health Foundation, and Heart To Heart International. She is also on the Advisory Boards of the California Health Care Foundation Innovation Fund, the
American Heart Association Innovation Think Tank, global digital health organization HealthXL and NASA’s Translational Research Institute. Lisa is a Fellow of the inaugural class of the Aspen Institute’s
Health Innovators Fellowship and a member of the Aspen Global Leadership Network. Through her Venture Valkyrie media company, Lisa writes a widely read blog on healthcare and healthcare investing at http://venturevalkyrie.com . She published her
first book in 2013: Tech Tonics, Can Passionate Entrepreneurs Heal Healthcare with Technology, coauthored with Dr. David Shaywitz. Together they also host a popular podcast, also called Tech Tonics, focused on the people and passion at the intersection
of technology and health.
Lisa an M.A. in political science, a B.A. in political science and a B.A. in mass communications, all from the University of California, Berkeley.
-
What corporate culture characteristics make or break startups?
As someone who invests in small companies where the culture is really, really important to outcome, it is something I think about almost all of the time when I perform diligence on companies and sit on their boards.
-
The convergence of the technology and medical device industries is no longer a practical impossibility
I used to feel like the only person who had ever given any thought to the convergence of tech and devices at medtech conferences. I’m so glad to see the dawn of this new convergence thinking become more and more generally accepted.
-
Payer’s Place: Dawn Maroney
Dawn Maroney, President, Markets of Alignment Health and CEO of Alignment Health Plan, to discuss how they are using technology to provide better service and care to consumers.
-
Improving the patient experience: The next frontier in health tech
It’s time for entrepreneurs and purchasers to remember that the patient isn’t a component of a healthcare technology plan, they are the point of it.
-
The power of listening in healthcare
In his commencement address, Siddhartha Mukherjee exhorted the audience and especially the young graduates to commit to establishing themselves as the “listening generation or Generation L and the power of empathy to figure out the best way to deliver care.
-
As digital health companies proliferate, it’s getting tougher to spot the strongest businesses
It used to be conventional wisdom that the reason healthcare IT deals were appealing, at least compared to medical devices and biotech, is because they needed far less capital to get to the promised land.
-
The lines that define healthcare industry segments are blurring, but what will be the result?
Take a giant step back and you can see that all of the major players are undergoing major material changes in how they define themselves and what they offer to the market. The lines between retail and insurance companies and the pharma and technology industries are melting away.
-
MedCity Influencers, Diagnostics
Genetic testing has reached an exciting tipping point, but it’s also the subject of parody
There are over 70,000 genetic tests on the market and up to 10 new ones make an appearance every day. Many offer exciting prospects for healthcare, but numerous companies make claims such as being able to customize a diet to fit one’s genomic profile or predicting the athletic abilities of one’s children.
-
Health IT, MedCity Influencers
At HIMSS18, pharma and health IT become more intimate and telemedicine breaks out of the dungeon
Odd bedfellows among pharma and HIT, consumer and HIT, even among tech companies once considered rivals or in different areas of the value chain are coming together and figuring out how dogs and cats can not just get along, but create better, more cuddly offspring.
-
This is how astronauts and space exploration can help us address healthcare challenges
It’s pretty cool to think about how audacious innovation for space may lead to dramatic innovation here on Earth…how an actual moonshot may result in a terrestrial medical moonshot being achieved.
-
Applying Remote Patient Monitoring to Surgery Prep and Recovery, Oncology and Women’s Health
Join us to learn about the latest trends in remote monitoring and how to extend its benefits beyond chronic conditions to more patients – all while using fewer staff resources.
-
The J.P. Morgan Healthcare Conference in the #MeToo era
This year, more than any other, there was an abundance of women at events surrounding the J.P. Morgan Healthcare conference. While the main event featured a mere 20 total women CEOs, the tone on the outside of the Westin St. Francis hotel was somewhat better than in prior years.
-
Want to stay healthy? Think about getting a dog
A new study suggests owning a dog can significantly reduce the risk of a cardiovascular-related death. I challenge you to show me any drug or surgery that does the same without side effects and at a comparable cost.
-
Why financial services industry disruption is not a proxy for healthcare business innovation
Financial services innovation models aren’t a great proxy for how to disrupt healthcare. Here are a few reasons why.
-
What can innovators learn from children’s books?
Lisa Suennen says there should be a book club for innovators and would-be innovators that teaches them the way towards innovation through children’s literature. She offers a peek at what the book list would look like.
-
Devices & Diagnostics, Startups, MedCity Influencers
This is why a direct-to-consumer medical device company is a risky undertaking
This is a cautionary tale for entrepreneurs, whose passion for their work is always so admirable but who don’t always think through this consumer issue to its logical conclusion
-
Startups, MedCity Influencers, BioPharma
How women are fighting to be part of the new world order in healthcare, life sciences and beyond
Even at the J.P. Morgan Healthcare Conference, the tide seems to have turned. This year, there were at least eight events that I personally heard of that were women-only and overflowing.
Promoted
Payer’s Place: Dr. Anil Singh
Dr. Anil Singh shares his insights into the strategies employed by the organization to identify the most effective digital solutions for their members.
Promoted
Discover the Next-Gen Platform for Integrated Collaborative Care
Beyond EHRs and digital front doors, reducing the gaps in patient care journeys.
